Aakaar Medical Technologies IPO subscribed 2.28 times on the last day, while A retail quota was subscribed 1.93 times, QIB was subscribed 3.51 times, and NII quota subscribed by 1.48 times, respectively.
Details About Aakaar Medical Technologies IPO
Aakaar Medical Technologies got approval from SEBI for an IPO of ₹27 crores. The face value of each share was ₹10. Moreover, the company has set up a price band between ₹68 to ₹72 per share.
In this IPO a total of 1600 shares were available in 1 lot size for the minimum Retail category and for the maximum retail category.
While S-HNI (Min) total of 3200 shares in a 2-lot size.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹1,15,200 and maximum investment of ₹1,15,200.
- Small HNI (S-HNI): Minimum investment of ₹2,30,400.
Subscription duration of Aakaar Medical Technologies IPO
Aakaar Medical Technologies’ IPO opening date was June 20, 2025, and the closing date was June 24, 2025. The allotment of Aakaar Medical Technologies was finalized on June 25, 2025, while the IPO listing is on June 27, 2025.
Funds Deployment of This Company
- Funding the working capital requirements of the Company
- General corporate purposes.
About Aakaar Medical Technologies IPO
Aakaar Medical Technologies Ltd., founded in 2013, is a top medical company that offers a variety of aesthetic and cosmetic products and devices.
The company is recognized for providing specialized products for dermatologists, plastic surgeons, aesthetic doctors, and cosmetologists. Its product range includes both in-house developed items and imported devices from countries like South Korea, Spain, Italy, and Austria. These products are used or sold by medical professionals for various cosmetic and aesthetic treatments.
The company’s product range consists of Homecare and professional skin care, Injectable and contouring, Homecare for skin, Professional Hair Care, Professional Skincare products, Hair Growth Serum & Tablets, Medifacial Kit, Device for urinary incontinence, Tattoo removal, pigmentation, and skin rejuvenation devices, Laser Hair Reduction devices and Hair Transplant Device.
Financial Background of Aakaar Medical Technologies IPO
The company earned ₹61.76 crores in revenue in 2025, up from ₹46.27 crores in 2024. Its profit also increased to ₹6.04 crores in 2025, compared to ₹2.87 crores in 2024.
